Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01515384 · ClinicalTrials.gov registry record · Phase 1
A Trial of 18F-AV-133 Positron Emission Tomography (PET)
A Phase 1 study, sponsored by Avid Radiopharmaceuticals.
- Terminated
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT01515384 is a Phase 1 study that was terminated before completion, run by Avid Radiopharmaceuticals. The registered enrollment target is 19 participants.
The verdict
NCT01515384, a Phase 1 study, was terminated before completion, sponsored by Avid Radiopharmaceuticals.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and pancreas imaging properties of 18F-AV-133.
Interventions
- DRUG 18F-AV-133
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01515384
The ClinicalTrials.gov registry entry for NCT01515384 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avid Radiopharmaceuticals, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 18F-AV-133 is the first listed.
NCT01515384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01515384 about?
NCT01515384 is a clinical study titled "A Trial of 18F-AV-133 Positron Emission Tomography (PET)". The purpose of this study is to evaluate the safety and pancreas imaging properties of 18F-AV-133.
What is the current status of trial NCT01515384?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2010-06. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01515384?
The interventions under investigation include: 18F-AV-133 (DRUG).
Who is sponsoring clinical trial NCT01515384?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.